Health In Tech, Inc. Class A (HIT) AI Stock Analysis

• Market Cap: $165.78M
• Dividend Yield: N/A
• Average Volume (3M): 410.17K
• Price to Earnings (P/E): 120.5
• Beta (1Y): 1.73
• Revenue Growth: 29.68%
• EPS Growth: -27.27%
• Country: US
• Employees: 73
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.01
• Shares Outstanding: 44,689,290
• 10 Day Avg. Volume: 356,798
• 30 Day Avg. Volume: 410,168
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.25
• Enterprise Value/Revenue: 1.54
• Enterprise Value/Gross Profit: 2.16
• Enterprise Value/Ebitda: 16.25
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 68 Neutral
• Price Target: $3.00 ▼(-0.66% Downside)

Health In Tech, Inc. demonstrates strong financial performance with significant revenue growth and a robust balance sheet. The positive sentiment from the earnings call further supports the company's growth prospects. However, technical indicators suggest a bearish trend, and the high P/E ratio indicates overvaluation, which tempers the overall score.

Positive Factors

Revenue Growth

The significant revenue growth indicates strong market demand and effective business strategies, supporting long-term expansion and sustainability.

Strategic Partnerships

The partnership for HITChain aims to enhance operational efficiency and trust in claims processing, potentially transforming industry standards and expanding HIT's market influence.

Management Quality

Leadership changes with experienced executives in AI and marketing are likely to drive innovation and revenue growth, enhancing competitive positioning.

Negative Factors

Declining Profit Margins

Shrinking profit margins suggest challenges in cost management, which could hinder profitability and operational efficiency if not addressed.

Increased Administrative Expenses

Rising administrative costs, especially as a public company, could pressure margins and reduce financial flexibility if not managed effectively.

Decreased Return on Equity

A significant drop in return on equity indicates potential inefficiencies in generating profits from shareholders' equity, impacting investor confidence.

Health In Tech, Inc. Class A Business Overview & Revenue Model

Company Description

Health In Tech, Inc. Class A (HIT) is a pioneering company operating at the intersection of healthcare and technology. Focused on delivering innovative solutions, HIT specializes in developing advanced digital health platforms, telemedicine services, and health analytics tools. The company's core offerings include a suite of applications that enhance patient engagement, streamline communication between healthcare providers, and leverage artificial intelligence to improve clinical decision-making. Committed to transforming the healthcare landscape, HIT serves a diverse clientele that includes hospitals, clinics, and insurance providers.

How the Company Makes Money

Health In Tech, Inc. generates revenue through multiple streams. The primary revenue model is subscription-based, where healthcare providers and organizations pay monthly or annual fees for access to HIT's digital health platforms and services. Additionally, HIT earns income from transaction fees associated with its telemedicine services, where patients are charged for virtual consultations. The company also monetizes its analytics tools by offering premium features and insights to healthcare organizations seeking to enhance their operational efficiency. Strategic partnerships with healthcare providers and technology companies further bolster HIT's earnings, allowing for co-development of solutions and expanding market reach.

Health In Tech, Inc. Class A Financial Statement Overview

Summary

Health In Tech, Inc. shows strong revenue growth and a solid balance sheet with low leverage. However, declining profitability margins and reduced return on equity indicate potential operational inefficiencies. Cash flow generation is robust, though there is a need to enhance earnings quality to sustain long-term growth.

Income Statement

Health In Tech, Inc. has demonstrated significant revenue growth, increasing from $5.77 million in 2022 to $19.49 million in 2024. The company's gross profit margin is strong at approximately 79.2%, although the net profit margin has declined from 12.9% to 3.4% over the same period. The EBIT and EBITDA margins also show a downward trend, indicating potential challenges in controlling operating expenses.

Balance Sheet

The balance sheet reflects a robust equity position, with a high equity ratio of around 83.5%. The debt-to-equity ratio is low at 0.02, highlighting a conservative leverage approach. Return on equity has decreased from 40.6% in 2023 to 5.1% in 2024, suggesting a need for improved profitability.

Cash Flow

Operating cash flow has improved, and free cash flow increased significantly by 232% from 2023 to 2024. However, the operating cash flow to net income ratio decreased, indicating that cash generation relative to net profits has weakened. The company maintains a solid free cash flow to net income ratio, ensuring free cash flow remains healthy.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	26.69M	19.49M	19.15M	5.77M
Gross Profit	18.94M	15.44M	16.85M	5.44M
EBITDA	2.52M	1.93M	3.76M	205.58K
Net Income	1.36M	670.48K	2.48M	79.74K
Balance Sheet
Total Assets	22.18M	15.77M	11.50M	28.56M
Cash, Cash Equivalents and Short-Term Investments	8.14M	7.85M	2.42M	1.49M
Total Debt	174.36K	206.69K	1.92M	316.09K
Total Liabilities	5.75M	2.60M	5.41M	27.14M
Stockholders Equity	16.42M	13.17M	6.09M	1.05M
Cash Flow
Free Cash Flow	1.31M	1.28M	384.52K	-436.63K
Operating Cash Flow	3.60M	2.18M	1.53M	782.75K
Investing Cash Flow	-2.22M	-836.75K	-1.94M	-1.22M
Financing Cash Flow	4.60M	4.09M	1.34M	1.88M

Health In Tech, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.02
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HIT, the sentiment is Negative. The current price of 3.02 is below the 20-day moving average (MA) of 3.30, below the 50-day MA of 3.16, and above the 200-day MA of 2.61, indicating a neutral trend. The MACD of -0.05 indicates Positive momentum. The RSI at 44.83 is Neutral, neither overbought nor oversold. The STOCH value of 31.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HIT.

Health In Tech, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HIT	68 Neutral	$165.78M	120.49	11.86%	―	29.68%	-27.27%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
HKIT	55 Neutral	$67.97M	―	-6.17%	―	-47.44%	-318.95%
VS	39 Underperform	$10.27M	―	-15.68%	―	1873.85%	91.70%
TONX	38 Underperform	$236.95M	―	-51.38%	―	4095.10%	93.91%

Health In Tech, Inc. Class A Corporate Events

Health In Tech Grants Stock Awards to Executives

On August 15, 2025, Health In Tech, Inc. granted restricted stock awards to its CEO, CFO, and CTO as part of their efforts to develop two new programs. These awards, which are part of the company’s Equity Incentive Plan, will vest in equal monthly installments over a period of 24 months, contingent upon the successful launch and operation of the programs.

The most recent analyst rating on (HIT) stock is a Buy with a $3.50 price target. To see the full list of analyst forecasts on Health In Tech, Inc. Class A stock, see the HIT Stock Forecast page.